glp-1 weight watchers program WeightWatchers revamps brand identity to better tap into craze Weight Watchers Program - Apps
Description
Sie wirken aufgrund ihrer strukturellen hnlichkeit mit dem Peptidhormon GLP-1 (Glucagon-like peptide 1)
they exist only in clinical trials with varying investigational wearing durations
("PolyPid" or the "Company"), unveiled its long-acting GLP-1 receptor agonists (glucagon-like peptide-1 RA) delivery platform which aims to subcutaneously release GLP-1 RA for approximately 60 days, significantly longer than current weekly injection regimens
There has been a lot of buzz about what these drugs may be capable of, and you can see below, GLP-1s are being investigated in a range of conditions
The study, published in the Clinical Journal of the American Society of Nephrology, looked at incretin hormone levels in patients with kidney disease and compared them to those without kidney disease
